ZA200906433B - Recombinant expression vectors elements (reves) for enchancing expression of recombinant proteins in host cells - Google Patents

Recombinant expression vectors elements (reves) for enchancing expression of recombinant proteins in host cells

Info

Publication number
ZA200906433B
ZA200906433B ZA2009/06433A ZA200906433A ZA200906433B ZA 200906433 B ZA200906433 B ZA 200906433B ZA 2009/06433 A ZA2009/06433 A ZA 2009/06433A ZA 200906433 A ZA200906433 A ZA 200906433A ZA 200906433 B ZA200906433 B ZA 200906433B
Authority
ZA
South Africa
Prior art keywords
recombinant
expression
reves
enchancing
host cells
Prior art date
Application number
ZA2009/06433A
Inventor
Wendy R Gion
Gerald R Carson
Hong Gao
Yune Z Kunes
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of ZA200906433B publication Critical patent/ZA200906433B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA2009/06433A 2007-03-30 2009-09-15 Recombinant expression vectors elements (reves) for enchancing expression of recombinant proteins in host cells ZA200906433B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92114107P 2007-03-30 2007-03-30
PCT/US2008/004063 WO2008121324A2 (en) 2007-03-30 2008-03-28 Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells

Publications (1)

Publication Number Publication Date
ZA200906433B true ZA200906433B (en) 2014-03-26

Family

ID=39795081

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2009/06433A ZA200906433B (en) 2007-03-30 2009-09-15 Recombinant expression vectors elements (reves) for enchancing expression of recombinant proteins in host cells

Country Status (16)

Country Link
US (2) US7935808B2 (en)
EP (1) EP2142560A4 (en)
JP (2) JP5432117B2 (en)
KR (2) KR20100014724A (en)
CN (1) CN101652379B (en)
AU (1) AU2008233196B2 (en)
BR (1) BRPI0809361A2 (en)
CA (1) CA2681581A1 (en)
IL (1) IL201231A0 (en)
MX (1) MX2009010492A (en)
NZ (1) NZ580378A (en)
RU (1) RU2518340C2 (en)
SG (1) SG182953A1 (en)
TW (1) TW200907059A (en)
WO (1) WO2008121324A2 (en)
ZA (1) ZA200906433B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100014724A (en) * 2007-03-30 2010-02-10 아보트 러보러터리즈 Recombinant expression vector elements(reves) for enhancing expression of recombinant proteins in host cells
JP5808249B2 (en) * 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド Antibody isolation and purification using protein A affinity chromatography
ES2440321T3 (en) 2009-02-27 2014-01-28 Novartis Ag Methods to select eukaryotic cells that express a heterologous protein
JP2013502217A (en) * 2009-08-17 2013-01-24 ノックス テクノロジーズ インコーポレイテッド Cloning and expression of arNOX protein 9-transmembrane superfamily (TM9SF), method and use
AU2010313395A1 (en) 2009-10-30 2012-05-10 Abbvie Inc. sORF constructs and multiple gene expression
SG10201601882PA (en) 2011-12-22 2016-04-28 Hoffmann La Roche Expression Vector Organization, Novel Production Cell Generation Methods And Their Use For The Recombinant Production Of Polypeptides
EP3354660A1 (en) * 2011-12-22 2018-08-01 F. Hoffmann-La Roche AG Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
WO2013175491A2 (en) * 2012-03-30 2013-11-28 Biogenomics Limited Stable expression system for eukaryotic cells
KR102073748B1 (en) 2013-01-31 2020-02-05 한미약품 주식회사 Recombinant yeast transformant and process for preparing immunoglobulin Fc fragment employing the same
WO2015017823A1 (en) * 2013-08-02 2015-02-05 The Uab Research Foundation Tetravalent pneumococcal serogroup 6z
RU2546249C2 (en) 2013-08-07 2015-04-10 Силезиа Груп Пте. Лтд. Composition for amplification of transgene expression in eucariotic cells, and method for increasing generation of target protein coded with transgene
JP6526025B2 (en) 2013-10-16 2019-06-05 オンコバイオロジクス，インコーポレイティド Buffer solution formulation for enhancing antibody stability
WO2016118707A1 (en) 2015-01-21 2016-07-28 Oncobiologics, Inc. Modulation of charge variants in a monoclonal antibody composition
WO2016151599A1 (en) 2015-03-25 2016-09-29 Biogenomics Limited A bigenic mammalian expression vector
AU2017213775A1 (en) 2016-02-03 2018-08-16 Outlook Therapeutics, Inc. Buffer formulations for enhanced antibody stability
WO2019055471A1 (en) * 2017-09-18 2019-03-21 Amyris, Inc. Methods for producing full-length antibodies
WO2020006486A1 (en) * 2018-06-29 2020-01-02 Krystal Biotech, Inc. Compositions and methods for antibody delivery
PT115073A (en) 2018-10-09 2020-05-29 Inst De Biologia Molecular E Celular Ibmc NUCLEIC ACID TO ACTIVATE PROTEIN EXPRESSION AND PRODUCTION
CN110592090A (en) * 2019-10-30 2019-12-20 福建师范大学 SSA4 gene promoter and pichia pastoris expression vector for driving exogenous gene transcription by using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052027T5 (en) 1988-11-11 2005-04-16 Medical Research Council IMMUNOGLOBULINE VARIABLE DOMAIN SEQUENCE CLONING.
US6596514B2 (en) 1996-01-11 2003-07-22 Immunex Corporation Expression augmenting sequence elements (EASE) for eukaryotic expression systems
DE69730592T2 (en) 1996-01-11 2005-09-29 Immunex Corp., Thousand Oaks EXPRESSION-GROWING SEQUENCE ELEMENTS FOR EUKARYONTIC EXPRESSION SYSTEMS
US6197591B1 (en) * 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
SG141239A1 (en) 2001-01-26 2008-04-28 Selexis Sa Matrix attachment regions and methods for use thereof
ATE496134T1 (en) * 2002-03-29 2011-02-15 Xoma Technology Ltd MULTIGENE VECTORS AND METHODS FOR INCREASED EXPRESSION OF RECOMBINANT POLYPEPTIDES
US7326567B2 (en) * 2003-11-12 2008-02-05 Schering Corporation Plasmid system for multigene expression
SG2014010029A (en) 2005-08-19 2014-08-28 Abbott Lab Dual variable domain immunoglobin and uses thereof
SI3339445T1 (en) * 2006-09-08 2020-12-31 Abbvie Bahamas Ltd. Interleukin -13 binding proteins
KR20100014724A (en) * 2007-03-30 2010-02-10 아보트 러보러터리즈 Recombinant expression vector elements(reves) for enhancing expression of recombinant proteins in host cells

Also Published As

Publication number Publication date
US20080241883A1 (en) 2008-10-02
AU2008233196B2 (en) 2011-10-13
EP2142560A2 (en) 2010-01-13
AU2008233196A1 (en) 2008-10-09
CN101652379B (en) 2014-05-14
US8410259B2 (en) 2013-04-02
CN101652379A (en) 2010-02-17
RU2009140146A (en) 2011-05-10
US7935808B2 (en) 2011-05-03
WO2008121324A2 (en) 2008-10-09
KR20100014724A (en) 2010-02-10
IL201231A0 (en) 2010-05-31
JP2014012014A (en) 2014-01-23
EP2142560A4 (en) 2010-12-01
JP2010523082A (en) 2010-07-15
RU2518340C2 (en) 2014-06-10
US20110201053A1 (en) 2011-08-18
SG182953A1 (en) 2012-08-30
JP5432117B2 (en) 2014-03-05
NZ580378A (en) 2012-11-30
WO2008121324A3 (en) 2008-12-11
MX2009010492A (en) 2009-10-19
BRPI0809361A2 (en) 2014-09-02
KR20140001229A (en) 2014-01-06
CA2681581A1 (en) 2008-10-09
TW200907059A (en) 2009-02-16

Similar Documents

Publication Publication Date Title
ZA200906433B (en) Recombinant expression vectors elements (reves) for enchancing expression of recombinant proteins in host cells
HK1250518A1 (en) Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
AU2016202426A1 (en) Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
ZA201204383B (en) Expression of hexose kinase in recombinant host cells
ZA201001933B (en) Cell-permeabilising peptides and polypeptides for microbial cells
IL202213A0 (en) Recombinant protein production in avian ebxr cells
EP2315833B8 (en) Vectors for delivery of light-sensitive proteins and methods of use
HRP20190025T1 (en) Recombinant bacterial host cell for protein expression
EP2406038A4 (en) Abrasive articles including fused zirconia alumina grain having an improved shape
EP2593469A4 (en) Modified polypeptides and proteins and uses thereof
EP2242840A4 (en) Recombinant virus production using mammalian cells in suspension
EP2376647A4 (en) Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system
EP2242505A4 (en) Glycoconjugation of polypeptides using oligosaccharyltransferases
EP2246064A4 (en) Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof
DK2089524T3 (en) DNase expression in recombinant host cells
BR112014031039A2 (en) recombinant DNA elements for the expression of recombinant proteins in a host cell.
EP2935581A4 (en) Expression vectors for recombinant protein production in mammalian cells
EP2504357A4 (en) Recombinant filaggrin polypeptides for cell importation
EP2245160A4 (en) Cell surface display of proteins
EP2598636A4 (en) Vectors and methods for recombinant protein expression
PL2443232T3 (en) System for the heterologous expression of a viral protein in a ciliate host cell
EP2274418A4 (en) Human host cell for producing recombinant proteins with high quality and quantity
GB0725201D0 (en) Peptide fusion proteins
HK1154046A1 (en) Methods and compositions for production of recombinant protein in hbx- expressing mammalian cells hbx
EP2382317A4 (en) Tor-interacting proteins (tips) and genes therefor